Drug Profile
Ivabradine/metoprolol - Servier
Alternative Names: IMPLICOR; Metoprolol/ivabradineLatest Information Update: 25 Jan 2019
Price :
$50
*
At a glance
- Originator Servier
- Class Antihypertensives; Benzazepines; Bradycardic agents; Class II antiarrhythmics; Heart failure therapies; Heterocyclic bicyclo compounds; Ischaemic heart disorder therapies; Propanolamines; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Hyperpolarisation activated cation channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Angina pectoris
Most Recent Events
- 25 Jan 2019 Chemical structure information added
- 23 Jan 2019 Ivabradine/metoprolol is not yet available in Netherlands, Austria, Belgium, Bulgaria, Croatia, Cyprus, Denmark, Finland, France, Germany, Hungary, Italy, Latvia, Liechtenstein, Lithuania, Malta, Norway, Romania, Slovenia, Sweden and Slovakia (PO)
- 23 Jan 2019 Launched for Angina pectoris in Estonia, prior January 2019 (PO)